-
Highlights of the safety committee: October 2023
Highlights of the safety committee: October 2023
-
Highlights of the safety committee: October 2023
Highlights of the safety committee: October 2023
At its monthly meeting, EMA's safety committee, the PRAC, discussed new safety information for medicines containing omega-3-acid ethyl esters
-
New ACT EU video released
New ACT EU video released
-
New ACT EU video released
New ACT EU video released
Watch a video to learn about how the Accelerating Clinical Trials in the EU (ACT EU) initiative is transforming the way clinical trials are initiated, designed, and run
-
CHMP highlights: September 2023
CHMP highlights: September 2023
-
CHMP highlights: September 2023
CHMP highlights: September 2023
EMA's human medicines committee (CHMP) recommended nine new medicines for approval in the EU at its September 2023 meeting.
-
EMA cooperation with HTA bodies in the EU
EMA cooperation with HTA bodies in the EU
-
EMA cooperation with HTA bodies in the EU
EMA cooperation with HTA bodies in the EU
The EMA-EUnetHTA cooperation is coming to an end, but preparations are continuing for the implementation of the regulation on health technology assessment.
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal